🇺🇸 CPA in United States
13 US adverse-event reports
Safety signals — FAERS
Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.
- Window: 22 April 2025 – 22 April 2026
- Total reports: 13
Most-reported reactions
- Asthenia — 2 reports (15.38%)
- Dizziness — 2 reports (15.38%)
- Dyspnoea — 2 reports (15.38%)
- Atrial Fibrillation — 1 report (7.69%)
- Blood Pressure Decreased — 1 report (7.69%)
- Cardiac Failure Congestive — 1 report (7.69%)
- Cardiomyopathy — 1 report (7.69%)
- Chest Discomfort — 1 report (7.69%)
- Confusional State — 1 report (7.69%)
- Coordination Abnormal — 1 report (7.69%)
Other Oncology approved in United States
Frequently asked questions
Is CPA approved in United States?
CPA does not currently have US marketing authorisation in our dataset.
Who is the marketing authorisation holder for CPA in United States?
ImmunoVaccine Technologies, Inc. (IMV Inc.) is the originator. The local marketing authorisation holder may differ — check the official source linked above.